This is a preview of subscription content, log in via an institution to check access.
Reference
He T, et al. Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6. Alimentary Pharmacology and Therapeutics : 24 Aug 2017. Available from: URL: http://doi.org/10.1111/apt.14271
Rights and permissions
About this article
Cite this article
DAAs cost effective for HCV genotypes 2−5. PharmacoEcon Outcomes News 786, 12 (2017). https://doi.org/10.1007/s40274-017-4302-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4302-3